United Therapeutics (UTHR) Total Debt Growth (1y) (2011 - 2025)
United Therapeutics (UTHR) Total Debt Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.67 Bn | 34.93 Bn | 1.97 Bn | -0.14% |
| 2 | Zoetis | 30.59 Bn | 28.65 Bn | 1.62 Bn | 37.52% |
| 3 | RedHill Biopharma | 26.22 Bn | 26.22 Bn | - | - |
| 4 | United Therapeutics | 23.80 Bn | 21.65 Bn | 648.10 Mn | - |
| 5 | Curaleaf Holdings | 23.70 Bn | 23.70 Bn | 157.29 Mn | - |
| 6 | Viatris | 18.69 Bn | 16.89 Bn | 1.16 Bn | -9.51% |
| 7 | Neurocrine Biosciences | 16.86 Bn | 15.54 Bn | 800.70 Mn | - |
| 8 | Elanco Animal Health | 11.99 Bn | 11.57 Bn | 785.00 Mn | -9.19% |
| 9 | Dr Reddys Laboratories | 11.65 Bn | 11.51 Bn | - | 90.20% |
| 10 | Vireo Growth | 10.64 Bn | 10.52 Bn | 59.30 Mn | 217.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -66.67% |
| Dec 31, 2024 | -57.14% |
| Sep 30, 2024 | -50.00% |
| Jun 30, 2024 | -37.50% |
| Mar 31, 2024 | -25.00% |
| Dec 31, 2023 | -12.50% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | -5.88% |
| Sep 30, 2020 | -20.00% |
| Jun 30, 2020 | -23.81% |